A new model (Alfalfa-Warfarin-GIB) for predicting the risk of major gastrointestinal bleeding in warfarin patients

[1]  Nianxu Huang,et al.  A new model to predict the risk of major gastrointestinal bleeding in patients on direct oral anticoagulants (dabigatran and rivaroxaban) , 2022, British journal of clinical pharmacology.

[2]  A. Santamaría,et al.  Severity of gastrointestinal bleeding is similar between patients receiving direct oral anticoagulants or vitamin K antagonists. , 2022, Revista Espanola de Enfermedades Digestivas.

[3]  A. Zullo,et al.  Gastroprotection in patients on antiplatelet and/or anticoagulant therapy: a position paper of National Association of Hospital Cardiologists (ANMCO) and the Italian Association of Hospital Gastroenterologists and Endoscopists (AIGO). , 2020, European journal of internal medicine.

[4]  B. Holtz.  Patients Perceptions of Telemedicine Visits Before and After the Coronavirus Disease 2019 Pandemic. , 2020, Telemedicine journal and e-health : the official journal of the American Telemedicine Association.

[5]  Le Zhang,et al.  Risk of Major Gastrointestinal Bleeding With New vs Conventional Oral Anticoagulants-a Systematic Review and Meta-analysis. , 2020, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[6]  L. Køber,et al.  Risk of gastrointestinal bleeding associated with oral anticoagulation and non-steroidal anti-inflammatory drugs in patients with atrial fibrillation: a nationwide study. , 2019, European heart journal. Cardiovascular pharmacotherapy.

[7]  A. Kfoury,et al.  Novel Model to Predict Gastrointestinal Bleeding During Left Ventricular Assist Device Support: The Utah Bleeding Risk Score , 2018, Circulation. Heart failure.

[8]  J. Akiyama,et al.  New predictive model for acute gastrointestinal bleeding in patients taking oral anticoagulants: A cohort study , 2018, Journal of gastroenterology and hepatology.

[9]  M. Delgado-Rodríguez,et al.  Systematic review and meta-analysis. , 2017, Medicina intensiva.

[10]  Á. Lanas,et al.  Risk of gastrointestinal bleeding during anticoagulant treatment , 2017, Expert opinion on drug safety.

[11]  L. Strate,et al.  ACG Clinical Guideline: Management of Patients With Acute Lower Gastrointestinal Bleeding , 2016, The American Journal of Gastroenterology.

[12]  E. Tremoli,et al.  Gastrointestinal bleeding in patients receiving oral anticoagulation: Current treatment and pharmacological perspectives. , 2015, Thrombosis research.

[13]  P. Hsu,et al.  Gastrointestinal Hemorrhage in Warfarin Anticoagulated Patients: Incidence, Risk Factor, Management, and Outcome , 2014, BioMed research international.

[14]  L. Gerson.  Causes of gastrointestinal hemorrhage in patients with chronic renal failure. , 2013, Gastroenterology.

[15]  P. T. Onundarson,et al.  Screening for anemia in patients on warfarin facilitates diagnosis of gastrointestinal malignancies and pre-malignant lesions. , 2012, Thrombosis research.

[16]  D. Fisher,et al.  Does this patient have a severe upper gastrointestinal bleed? , 2012, JAMA.

[17]  Loren Laine,et al.  Management of Patients With Ulcer Bleeding , 2012, The American Journal of Gastroenterology.

[18]  D. Singer,et al.  A new risk scheme to predict warfarin-associated hemorrhage: The ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study. , 2011, Journal of the American College of Cardiology.

[19]  Gregory Y H Lip,et al.  A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey. , 2010, Chest.

[20]  J. Mandrekar.  Receiver operating characteristic curve in diagnostic test assessment. , 2010, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[21]  L. Jacobs.  Warfarin pharmacology, clinical management, and evaluation of hemorrhagic risk for the elderly. , 2008, Cardiology clinics.

[22]  M. Rich,et al.  Clinical classification schemes for predicting hemorrhage: results from the National Registry of Atrial Fibrillation (NRAF). , 2006, American heart journal.

[23]  S. Schulman,et al.  Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non‐surgical patients , 2005, Journal of thrombosis and haemostasis : JTH.

[24]  M. Pirmohamed,et al.  Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients , 2004, BMJ : British Medical Journal.

[25]  D. Nelson,et al.  Acute GI bleeding in the setting of supratherapeutic international normalized ratio in patients taking warfarin: endoscopic diagnosis, clinical management, and outcomes. , 2003, Gastrointestinal endoscopy.

[26]  Valentin Fuster,et al.  American Heart Association/American College of Cardiology Foundation guide to warfarin therapy. , 2003, Circulation.

[27]  F. Fulfaro,et al.  Gastrointestinal bleeding in advanced cancer patients. , 2000, Journal of pain and symptom management.

[28]  A. Graham,et al.  Gastrointestinal Bleeding. , 2016, Emergency medicine clinics of North America.

[29]  L. Strate,et al.  ACG Clinical Guideline: Management of Patients With Acute Lower Gastrointestinal Bleeding , 2016, The American Journal of Gastroenterology.

[30]  J. Lei,et al.  Risk of upper gastrointestinal bleeding from different drug combinations. , 2014, Gastroenterology.